Volume 103  ·   Issue 02  ·  1990

Aluminium citrate (Al-cit) was shown to be biologically effective in preventing silicosis. A total of 917 cases selected from both engineering corps of railway and coalmines with stage 0 or 0+ by radiographs were studied. Cases were randomly divided into Al-cit treatment group and control group with continuing dust exposures. Workers in the treatment group were injected with Al-cit at a dose of 120 mg Al/year and these in the control group received a consolatant or nothing during the period of five years. The radiographic changes demonstrated that Al-cit showed clear-cut effects in both retardation of the dust-induced fibrosis and decrease of the morbidity of silicosis.

The ultrastructural characteristics of platelets and the quantitative analysis of membrane glycoprotein (GP) IIb/IIIa quick-release reaction induced by high shear stress (HSS) were studied with transmission electron microscope and immunocolloidal gold staining. The results showed that platelets were activated and aggregated by HSS (50 dynes/cm2 or 100 dynes/cm2). Besides, HSS also caused a special platelet quick-release reaction which was called granule-membrane-fused lytic release (GFLR). GFLR differed from releases I and II which were induced by ADP and thrombin respectively. Granules were released quickly and lysis occurred when all granules had been discharged in GFLR. GFLR is a special form of platelet quick release induced by HSS and is called release III by the authors. In the process of platelet activation and lysis, the gold particles of GPIIb/IIIa were increasingly condensed. The possible reasons of increased surface expression of GPIIb/IIIa stimulated by HSS are also discussed.

Using tissue culture technique the present study for the first time indicated the antiviral effect of mangiferin and isomangiferin against type I herpes simplex virus (HSV-I). 4 methods were used for evaluating drug effectiveness (i.e., in vitro drug-on-virus direct action, simultaneous addition of drug-virus-inoculum to cell bottle, virus inoculation preceding drug addition, and drug addition followed by virus inoculation), it was readily found by log determination of HSV-I inhibition that isomangiferin somewhat exceeded such control drugs as acyclovir, idoxuridine, and cyclocytidine in log by 0.27-0.50, and that mangiferin was lower than isomangiferin in log by 0.53. The average plaque reduction rates of mangiferin and isomangiferin were 56.8% and 69.5% respectively. The antiviral effect of mangiferin and isomangiferin was presumably due to their capability of inhibiting virus replication within cells.

Schizencephaly is a neuronal migration malformation characterized by a cleft traversing the cerebral hemisphere. The cleft is lined by heterotopic gray matter, and the lips of the cleft may be fused (Type I)or separated (Type II). Often associated with anomalies of the septum pellucidum or corpus callosum, and polymicrogyria, schizencephaly has characteristic CT findings. Of 17 patients with this lesion detected by CT 2 had bilateral schizencephaly.

This paper reports the successful experiences of in vitro and in vivo studies on endoscopic fragmentation of gastric bezoars using a laser-ignited mini-explosive device. This new technique has been used clinically in 31 patients with gastric bezoars since January 1988. All patients were completely cured without any complication. The relationship between gastric bezoars and ulcers, and the technique of treatment were discussed.

An intravenous tryptophan tolerance test (ITrpTT) was designed for liver function since 95% Trp is metabolized by the liver. After an intravenous loading dose of 4 mg/kg body weight, serum levels of both free (F) and total (T) Trp were determined at 45 and 60 minutes. In normal controls and nonhepatic-disease patients, F45 (60) and T45 (60) did not exceed 7 μmol/L and 80 μmol/L, respectively, and F/T ratio not greater than 0.14. These were set up as cutoffs of upper normal limits. The test was abnormal in 87.5% of chronic persistent hepatitis (CPH) characterized by elevation of T45 (60), 100% of chronic active hepatitis (CAH) by elevation of F45 (60) and/or T45 (60), and 100% of hepatic cirrhosis by increase in F45 (60) and F/T ratio but not in T45 (60). The test seems to be more sensitive than the conventional tests for liver function. However, one should be cautious in interpretation of the test as there are some factors which might influence the Trp metabolism like exercise, alcoholism, corticosteroids and enzyme-inducers. It merits as an indication of liver dysfunction only when these factors are considered and excluded.

300 orthotopic liver transplantations in rats were performed for a variety of reasons. Male rats including Lewis, ACI, Wistar, and SD, with a body weight of 150 to 400 g, were used as liver donors and recipients. A midline abdominal incision was performed in both donor and recipient animals. The donor's liver was perfused through the aorta abdominalis. The recipient's liver was flushed via the protal vein (PV) with 2 ml of lactated Ringer's solution immediately after occlusion of the PV to make intrahepatic blood enter the circulation. The bile duct was reconstructed by end-to-end anastomosis via a Teflon catheter. The cuff technique was applied to anastomoses of the infrahepatic vena cava (VC) and PV. The suprahepatic VC was anastomosed using either suture or cuff technique. The operative success rate was 92.7% (278/300) on the average and 1-week survival rate 88.4% (199/225) in isografting. The model proved reliable for studies of liver transplantation.

A family with Fabry's disease including 2 hemizygotes and 3 heterozygotes is reported. The ocular manifestations include tortuosity of conjunctival vessels, Fabry's deposits underlying the anterior capsule of the lens and the whorl-like corneal dystrophy. Foam cells or mulberry cells in the urinary sediment and varying numbers of high electron-dense inclusions in the cytoplasm of endothelial cells in skin lesions are also important in diagnosing this disease. The concentrations of lipid peroxide in the sera of 2 hemizygotes in this report were higher than normal, possibly due to the patients weak ability of anti-oxygenation and malfunction of cells whose plasma membranes are easily attacked by free oxygen radicals. The biochemical and pathological changes, diagnosis, treatment, genetics and prevention of the disease are discussed.

Following the use of rigid ureteroscopic lithotripsy (URS) in 1984 and extracorporeal shock wave lithotripsy (ESWL) in 1987, the treatment for ureteral stones has undergone significant changes. Our experience showed that the successful rate of URS for 132 patients was 89.4% and for the upper third was rather low, percutaneous antegrade URS should be considered. 376 patients treated with ESWL in prone position with a successful rate of 96.8%. The applicability of open surgery was reduced to 17.8% in 1987 and 14.5% in 1988.

Eighteen patients with leukemia have received HLA-identical allogeneic bone marrow transplantation (BMT) at our hospital since 1981. Fifteen of these patients have been living without relapse. for prophylaxis of GVHD, MTX was used in 8 patients, and cyclosporine (CSP) together with MTX in 6 patients, 3 received multiple agents at much smaller dosage, including monoclonal antibody. All patients received intravenous placental gamma-globulin, and 16 received garlic extract. Three patients died. One, who neither received MTX, nor CSP died of hyperacute GVHD, one who did not receive garlic extract died of GMV pneumonia, and the third one died of tuberculosis 18 months after BMT.

Cardiovascular community control program in Beijing started in 1969. In the past 20 years, eleven such programs had been established, covering a total population of 750,000. For those programs that have been operating for over 5-10 years, a marked drop in the mortality and morbidity rates of hypertension, stroke and acute myocardial infarction has been observed. It is proposed that this type of community control program should be further expanded in the next ten years so as to materialize the WHO goal of "Health for all by 2000".